Liana Nikolaenko

759 total citations
41 papers, 372 citations indexed

About

Liana Nikolaenko is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Liana Nikolaenko has authored 41 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pathology and Forensic Medicine and 11 papers in Molecular Biology. Recurrent topics in Liana Nikolaenko's work include Lymphoma Diagnosis and Treatment (20 papers), CAR-T cell therapy research (18 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Liana Nikolaenko is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), CAR-T cell therapy research (18 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Liana Nikolaenko collaborates with scholars based in United States, Russia and Singapore. Liana Nikolaenko's co-authors include Alex F. Herrera, Geoffrey Shouse, Jennifer K. Yee, Ronald S. Swerdloff, Matthew Mei, Yanhe Lue, Samuel W. French, Leslie Popplewell, Stephen J. Forman and Amrita Krishnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Endocrinology.

In The Last Decade

Liana Nikolaenko

37 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liana Nikolaenko United States 12 156 131 83 80 60 41 372
Manpreet Chadha United States 12 179 1.1× 125 1.0× 125 1.5× 65 0.8× 27 0.5× 27 420
Shah Giashuddin United States 11 230 1.5× 138 1.1× 268 3.2× 50 0.6× 25 0.4× 25 572
Sandra Sapia Argentina 9 118 0.8× 64 0.5× 78 0.9× 19 0.2× 26 0.4× 16 315
Margaret Ottaviano Italy 11 193 1.2× 37 0.3× 153 1.8× 75 0.9× 46 0.8× 62 450
Robert Chew United States 6 90 0.6× 34 0.3× 63 0.8× 76 0.9× 25 0.4× 8 438
Ilenia Chatziandreou Greece 11 126 0.8× 21 0.2× 185 2.2× 76 0.9× 66 1.1× 23 409
Mosin Saleem Khan India 13 92 0.6× 69 0.5× 205 2.5× 29 0.4× 103 1.7× 39 417
Adriana Boes Netherlands 7 121 0.8× 48 0.4× 76 0.9× 74 0.9× 22 0.4× 9 345
William Koss United States 9 157 1.0× 50 0.4× 139 1.7× 38 0.5× 10 0.2× 19 426
Panagiota Tsioli Greece 9 112 0.7× 101 0.8× 126 1.5× 19 0.2× 19 0.3× 10 317

Countries citing papers authored by Liana Nikolaenko

Since Specialization
Citations

This map shows the geographic impact of Liana Nikolaenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liana Nikolaenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liana Nikolaenko more than expected).

Fields of papers citing papers by Liana Nikolaenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liana Nikolaenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liana Nikolaenko. The network helps show where Liana Nikolaenko may publish in the future.

Co-authorship network of co-authors of Liana Nikolaenko

This figure shows the co-authorship network connecting the top 25 collaborators of Liana Nikolaenko. A scholar is included among the top collaborators of Liana Nikolaenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liana Nikolaenko. Liana Nikolaenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steiner, Raphaël, Liana Nikolaenko, Ranjit Nair, et al.. (2025). Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial. Blood Advances. 9(21). 5556–5563.
2.
Ladbury, Colton, Sagus Sampath, Jeffrey Wong, et al.. (2024). Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy. Frontiers in Immunology. 15. 1419788–1419788. 1 indexed citations
3.
Mei, Matthew, Lu Chen, Sandrine Puverel, et al.. (2024). Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24(10). 724–731.e1.
4.
Rosa, Corinna La, Ibrahim Aldoss, Dongyun Yang, et al.. (2023). CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients after Stem Cell Transplant. Transplantation and Cellular Therapy. 29(2). S68–S69. 1 indexed citations
5.
Ong, Shin Yeu, Matthew Mei, Leslie Popplewell, et al.. (2023). Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma. American Journal of Hematology. 98(11). 1751–1761. 17 indexed citations
6.
Godfrey, James, Matthew Mei, Lu Chen, et al.. (2023). Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma. Haematologica. 109(2). 533–542. 10 indexed citations
7.
8.
Wong, Jeffrey Y.C., Liana Nikolaenko, Matthew Mei, et al.. (2023). Prognostic Significance of Positron Emission Tomography Delta Radiomics Following Bridging Therapy in Patients with Large B-Cell Lymphoma Undergoing CAR T-Cell Therapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). S53–S53. 2 indexed citations
9.
Mei, Matthew, Lu Chen, Sandrine Puverel, et al.. (2022). Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma. Blood. 140(Supplement 1). 9418–9419. 1 indexed citations
10.
Herrera, Alex F., Lu Chen, Lihua E. Budde, et al.. (2021). Pembrolizumab Plus Vorinostat Induces Responses in Patients with Hodgkin Lymphoma Who Are Refractory to Prior PD-1 Blockade. Blood. 138(Supplement 1). 234–234. 2 indexed citations
11.
Nikolaenko, Liana, Saurabh Chhabra, Noa Biran, et al.. (2020). Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation. Clinical Lymphoma Myeloma & Leukemia. 20(6). 407–414. 11 indexed citations
12.
Nikolaenko, Liana & Auayporn Nademanee. (2020). Brentuximab vedotin and its use in the treatment of advanced Hodgkin’s lymphoma. Future Oncology. 16(29). 2273–2282. 8 indexed citations
13.
Salhotra, Amandeep, Liana Nikolaenko, Lu Chen, et al.. (2019). Outcomes of Patients with T-Lymphoblastic Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single Center. Blood. 134(Supplement_1). 5729–5729. 1 indexed citations
14.
Shouse, Geoffrey & Liana Nikolaenko. (2019). Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders. Current Hematologic Malignancy Reports. 14(6). 570–576. 16 indexed citations
15.
Dadwal, Sanjeet, et al.. (2018). A Machine-Learning Sepsis Prediction Model for Patients Undergoing Hematopoietic Cell Transplantation. Blood. 132(Supplement 1). 711–711. 5 indexed citations
16.
Nikolaenko, Liana, Jasmine Zain, Steven T. Rosen, & Christiane Querfeld. (2018). CD30-Positive Lymphoproliferative Disorders. Cancer treatment and research. 176. 249–268. 7 indexed citations
17.
Stein, Cy A., Daniela Castanotto, Amrita Krishnan, & Liana Nikolaenko. (2016). Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs. Molecular Therapy — Nucleic Acids. 5. e346–e346. 22 indexed citations
18.
Nikolaenko, Liana, et al.. (2015). BREAST CANCER AND WOMAN’S REPRODUCTIVE FUNCTION (LITERATURE REVIEW). SHILAP Revista de lepidopterología. 11(1). 8–11. 2 indexed citations
19.
Nikolaenko, Liana, et al.. (2015). Laparoscopic surgery in patients with cancer of the corpus uteri and metabolic syndrome. P A Herzen Journal of Oncology. 4(3). 35–35. 2 indexed citations
20.
Wahjudi, Paulin N., Jennifer K. Yee, Michael A. Teitell, et al.. (2011). Turnover of nonessential fatty acids in cardiolipin from the rat heart. Journal of Lipid Research. 52(12). 2226–2233. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manpreet Chadha Breakdown of academic impact, for papers by Shah Giashuddin Breakdown of academic impact, for papers by Sandra Sapia Breakdown of academic impact, for papers by Margaret Ottaviano Breakdown of academic impact, for papers by Robert Chew Breakdown of academic impact, for papers by Ilenia Chatziandreou Breakdown of academic impact, for papers by Mosin Saleem Khan Breakdown of academic impact, for papers by Adriana Boes Breakdown of academic impact, for papers by William Koss Breakdown of academic impact, for papers by Panagiota Tsioli
Rankless by CCL
2026